Palatin Technologies, Inc.Mis à jour

Palatin Technologies (PTN)

Breakout, retest, potential triple bottom


Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.
Note
snapshot 33 cent limit in case of break down

Clause de non-responsabilité